GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elos Medtech AB (STU:EI9) » Definitions » Cyclically Adjusted FCF per Share

Elos Medtech AB (STU:EI9) Cyclically Adjusted FCF per Share : €0.20 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Elos Medtech AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Elos Medtech AB's adjusted free cash flow per share for the three months ended in Sep. 2023 was €-0.263. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.20 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Elos Medtech AB's average Cyclically Adjusted FCF Growth Rate was -12.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Elos Medtech AB was 12.10% per year. The lowest was 2.50% per year. And the median was 7.30% per year.

As of today (2024-06-10), Elos Medtech AB's current stock price is €17.70. Elos Medtech AB's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 was €0.20. Elos Medtech AB's Cyclically Adjusted Price-to-FCF of today is 88.50.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Elos Medtech AB was 92.83. The lowest was 35.76. And the median was 78.96.


Elos Medtech AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Elos Medtech AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elos Medtech AB Cyclically Adjusted FCF per Share Chart

Elos Medtech AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.33 0.32

Elos Medtech AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.30 0.24 0.22 0.20

Competitive Comparison of Elos Medtech AB's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Elos Medtech AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elos Medtech AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elos Medtech AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Elos Medtech AB's Cyclically Adjusted Price-to-FCF falls into.



Elos Medtech AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elos Medtech AB's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.263/130.2235*130.2235
=-0.263

Current CPI (Sep. 2023) = 130.2235.

Elos Medtech AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.230 100.544 0.298
201312 0.346 100.541 0.448
201403 0.051 99.788 0.067
201406 0.414 100.432 0.537
201409 0.079 100.161 0.103
201412 -0.024 100.225 -0.031
201503 -0.218 99.950 -0.284
201506 0.075 99.995 0.098
201509 -0.051 100.228 -0.066
201512 0.064 100.276 0.083
201603 0.113 100.751 0.146
201606 0.261 101.019 0.336
201609 0.408 101.138 0.525
201612 0.226 102.022 0.288
201703 0.114 102.022 0.146
201706 0.232 102.752 0.294
201709 0.085 103.279 0.107
201712 -0.010 103.793 -0.013
201803 -0.099 103.962 -0.124
201806 0.027 104.875 0.034
201809 -0.090 105.679 -0.111
201812 -0.027 105.912 -0.033
201903 -0.159 105.886 -0.196
201906 0.136 106.742 0.166
201909 0.005 107.214 0.006
201912 0.062 107.766 0.075
202003 0.031 106.563 0.038
202006 0.404 107.498 0.489
202009 0.380 107.635 0.460
202012 0.002 108.296 0.002
202103 -0.141 108.360 -0.169
202106 0.294 108.928 0.351
202109 0.018 110.338 0.021
202112 0.065 112.486 0.075
202203 -0.235 114.825 -0.267
202206 -0.044 118.384 -0.048
202209 0.293 122.296 0.312
202303 -0.202 127.042 -0.207
202306 0.021 129.407 0.021
202309 -0.263 130.224 -0.263

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Elos Medtech AB  (STU:EI9) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Elos Medtech AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=17.70/0.2
=88.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Elos Medtech AB was 92.83. The lowest was 35.76. And the median was 78.96.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Elos Medtech AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Elos Medtech AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Elos Medtech AB (STU:EI9) Business Description

Traded in Other Exchanges
N/A
Address
Torsgatan 5B, Gothenburg, SWE, 411 04
Elos Medtech AB operates in the medical technology business. It develops and produces medical technology products and components. The company operates through three business segments including Dental, Orthopedics, and Life science. Some of its products include Implants, Screws, Plates, Prosthetics, and Drills.

Elos Medtech AB (STU:EI9) Headlines

No Headlines